# Neomorph > Neomorph, Inc. is a venture-backed, clinical-stage biotechnology company in San Diego, California, > founded in 2020 to design molecular glue degraders — small molecules that bind an E3 ubiquitin > ligase, reshape it into a new "neomorphic" surface, and recruit previously undruggable proteins to > the proteasome for destruction. Neomorph runs no developer program and publishes no product API. > The only machine-readable interface reachable without credentials is the WordPress REST content API > behind neomorph.com, catalogued below. Generated: 2026-08-26 Method: generated Source: Generated by the API Evangelist enrichment pipeline from apis.yml and the artifacts in this repository, all of which were derived from live anonymous probes of https://neomorph.com and https://neomorph.com/wp-json on 2026-08-26. Neomorph does not publish an llms.txt of its own — https://neomorph.com/llms.txt returned HTTP 404 on that date. ## What this company does - Platform: molecular glue degraders reaching beyond cereblon to hundreds of E3 ligases and multiple proprietary degrons. Roughly 85% of the human proteome is considered undruggable by conventional small molecules because it lacks stable binding pockets; molecular glues bypass the requirement. - Lead programme: NEO-811, targeting ARNT/HIF-1β in clear cell renal cell carcinoma. First patient dosed in a Phase 1/2 trial, announced February 2026. - Pipeline beyond NEO-811: two undisclosed solid-tumor programmes, an early pipeline across multiple indications, and partnered target sets in oncology/immunology, neurology and cardiometabolic/rare disease. - Partnerships: Novo Nordisk (February 2024, cardiometabolic and rare disease), Biogen (October 2024, Alzheimer's, rare neurological and immunological disease), AbbVie (January 2025, oncology and immunology). - Financing: $109M Series A (December 2020), $100M Series B (April 2026). - Leadership: Philip Chamberlain, DPhil, CEO. Robert J. Hugin, Chairman of the Board (May 2026). - Headquarters: 5590 Morehouse Drive, San Diego, CA 92121. ## Company - [Website](https://neomorph.com/) - [About](https://neomorph.com/about-us/) - [Platform](https://neomorph.com/platform/): how Neomorph designs molecular glues - [Pipeline](https://neomorph.com/pipeline/): programmes, indications and stage - [Publications](https://neomorph.com/publications/): peer-reviewed literature - [Patients](https://neomorph.com/patients/) - [Careers](https://neomorph.com/careers/) - [News](https://neomorph.com/news/) - [News feed (RSS)](https://neomorph.com/feed/) - [Contact](https://neomorph.com/contact/) ## API surface There is no developer portal, no API reference, no SDK, no CLI, no MCP server, no agent card, no sandbox, no plans and no pricing. The following is the incidental REST interface of the corporate website's CMS. It is unsupported and unversioned by Neomorph, and it may change without notice. Base URL: https://neomorph.com/wp-json Contract definition: https://developer.wordpress.org/rest-api/ (WordPress core, not authored by Neomorph) Authentication: none required for anything listed here. All read-only. - [Discovery API](openapi/neomorph-discovery-api-openapi.yml): `GET /` returns the deployment's own route index — 432 routes across 23 namespaces. `GET /wp/v2/types`, `/wp/v2/taxonomies`, `/wp/v2/statuses`. Start here. - [News API](openapi/neomorph-news-api-openapi.yml): `GET /wp/v2/posts` — 14 press releases and media items, 2020-12-20 to 2026-05-13. - [Publications API](openapi/neomorph-publications-api-openapi.yml): `GET /wp/v2/resource` — 11 peer-reviewed papers, 2014-2022. Note the rest_base is `resource`, not `publications`. - [Team API](openapi/neomorph-team-api-openapi.yml): `GET /wp/v2/team` — 19 people; `GET /wp/v2/team_category` — Management (11), Board of Directors (7), Scientific Founders (4), Scientific Advisory Board (0). - [Pages API](openapi/neomorph-pages-api-openapi.yml): `GET /wp/v2/pages` — 15 corporate pages, including the NEO-811 programme page. - [Media API](openapi/neomorph-media-api-openapi.yml): `GET /wp/v2/media` — 111 attachments. - [Taxonomy API](openapi/neomorph-taxonomy-api-openapi.yml): `GET /wp/v2/categories` (2 terms), `GET /wp/v2/tags` (empty). - [Comments API](openapi/neomorph-comments-api-openapi.yml): `GET /wp/v2/comments` (empty). - [Search API](openapi/neomorph-search-api-openapi.yml): `GET /wp/v2/search` across every publicly queryable type. - [oEmbed API](openapi/neomorph-oembed-api-openapi.yml): `GET /oembed/1.0/embed` — conformant oEmbed 1.0. ## How to call it - Pagination: `?page=` and `?per_page=` (default 10, max 100). Read `X-WP-Total` and `X-WP-TotalPages` response headers, and the RFC 8288 `Link` header for `rel="next"`. All three are exposed cross-origin. - Sparse fields: `?_fields=id,title,link` works on every route and is the cheapest way to read this API. - Embedding: `?_embed` inlines featured media and taxonomy terms under `_embedded`. - Ordering and filtering: `?order=`, `?orderby=`, `?search=`, `?after=`, `?before=`, `?include=`, `?exclude=`, `?slug=`, plus `?categories=` on posts and `?team_category=` on team. - Errors are the WordPress WP_Error envelope, NOT RFC 9457: `{"code":"...","message":"...", "data":{"status":404}}` served as application/json. Branch on `code`; `message` is unstable prose. - No rate limits are published and no rate-limit headers are returned. Be polite. ## Known limitations an agent should plan for - Team job titles and biographies are NOT available through the API. `/wp/v2/team` has no `content` field and its `acf` object reads as an empty array anonymously. Fetch the HTML page at the object's `link` if you need more than a name and a portrait. - Publication citation metadata (journal, DOI, year, authors) is likewise held in ACF and reads empty. - `/wp/v2/users` is blocked at the edge and returns an HTML 403, not JSON — so the `author` id on every post and page is a dangling reference that cannot be resolved. - `context=edit` requires authentication; use `context=view` or `context=embed`. - No ETag or Last-Modified is returned, so conditional requests are not possible. The JSON surface is explicitly not edge-cached (`x-cache: BYPASS`). - The whole interface belongs to WordPress, not to Neomorph. A plugin or theme update can add or remove routes and fields without any announcement, because there is no changelog, no versioning policy, no deprecation policy and no status page. ## Not published by this provider Probed 2026-08-26, all absent: OpenAPI or Swagger (404 on /openapi.json, /openapi.yaml, /swagger.json, /v1/openapi.json, /api-docs, /docs, /redoc); GraphQL (404 on /graphql); MCP server (404 on /mcp, /wp-json/mcp, /.well-known/mcp — and the WordPress Abilities API at /wp-json/wp-abilities/v1/abilities is auth-gated with 401); A2A agent card (404 on /.well-known/agent-card.json and /.well-known/agent.json); every /.well-known/ path including security.txt, openid-configuration, oauth-authorization-server, oauth-protected-resource, api-catalog and ai-plugin.json; llms.txt; pricing (/pricing/ 404); developer portal (/developers/ 404, /api/ 404); status page (status.neomorph.com does not resolve); changelog (/changelog/ 404); first-party SDKs on npm, PyPI, RubyGems or crates.io; gRPC/protobuf; WSDL/SOAP; AsyncAPI or any documented webhook. ## Repository artifacts - [apis.yml](apis.yml): the APIs.json 0.23 index for this profile - [Authentication](authentication/neomorph-authentication.yml) - [Conventions and reversibility](conventions/neomorph-conventions.yml) - [Error catalog](errors/neomorph-problem-types.yml) - [Data model](data-model/neomorph-data-model.yml) - [Conformance](conformance/neomorph-conformance.yml) - [Lifecycle](lifecycle/neomorph-lifecycle.yml) - [Rate limits](rate-limits/neomorph-rate-limits.yml) - [Plans and pricing](plans/neomorph-plans-pricing.yml) - [MCP candidate](mcp/neomorph-mcp.yml) - [Well-known probe record](well-known/neomorph-well-known.yml) - [Domain security probe](security/neomorph-domain-security.yml) - [Overlay of API Evangelist enhancements](overlays/neomorph-content-overlay.yaml) - [Agent skills](skills/_index.yml) ## Provenance This is a third-party profile maintained by API Evangelist. It is not authored, endorsed or reviewed by Neomorph, Inc. Everything in it was assembled from publicly reachable material with no credentials. Corrections, re-scores and removal are free — see the repository README.